K.J. Harrison & Partners’s BriaCell Therapeutics Corp. Warrant BCTXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-68,885
| Closed | -$172K | – | 128 |
|
|
2023
Q2 | $172K | Sell |
68,885
-101,865
| -60% | -$254K | 0.03% | 201 |
|
|
2023
Q1 | $505K | Sell |
170,750
-37,626
| -18% | -$111K | 0.1% | 157 |
|
|
2022
Q4 | $581K | Sell |
208,376
-4,340
| -2% | -$12.1K | 0.11% | 152 |
|
|
2022
Q3 | $610K | Buy |
212,716
+31,440
| +17% | +$90.2K | 0.22% | 99 |
|
|
2022
Q2 | $472K | Buy |
181,276
+21,219
| +13% | +$55.2K | 0.13% | 130 |
|
|
2022
Q1 | $832K | Buy |
160,057
+44,910
| +39% | +$233K | 0.13% | 137 |
|
|
2021
Q4 | $541K | Sell |
115,147
-1,299
| -1% | -$6.1K | 0.08% | 189 |
|
|
2021
Q3 | $556K | Buy |
+116,446
| New | +$556K | 0.08% | 196 |
|
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$11K | – | 361 |
|
|
2021
Q1 | $11K | Buy |
+10,000
| New | +$11K | ﹤0.01% | 317 |
|